Gene Editing Provides Clues to Why Cancer Immunotherapy Often Fails.
JAMA, 318(17): 1641-1642 PMID 29114810 DOI 10.1001/jama.2017.15507
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.